Tuesday, June 19, 2012 3 to 4:30 p.m.

The Boston Convention and Exhibition Center, Maryland Pavillion, Boston, MA

The Montgomery County Department of Economic Development (MCDED) will host a press event during the 2012 BIO International Convention highlighting the nation’s ONLY local biotech investment incentive program, initiated by Montgomery County government; the role local biotech entrepreneurs, many from County-based federal labs like NIH and FDA, have and continue to play in the growth and success of the sector in the County; and a new, regional, industry-sector led intermediary created to bolster technology transfer into commercial success.

MedImmune CEO Peter Greenleaf will discuss the growth and success of that company in Montgomery County and the company’s leading role in supporting the newly formed BioHealth Innovation, Inc. (BHI) - an industry-led biotech intermediary. Human Genome Sciences CEO Tom Watkins will discuss the growth and success of that company in Montgomery County and the supportive local government and innovative initiatives and policies that support the sector. Montgomery County Executive Isiah Leggett will discuss the success of the County’s local biotech investment incentive program and BHI Board Chair Scott Carmer, Executive Vice President, Commercial Operations for MedImmune and BHI CEO Rich Bendis will discuss the early initiatives and successes of that new regional entity in bolstering the success of the region’s biotech sector.
Other discussions will include the key role the biotech industry is playing in the evolution of entrepreneurship, with Peter Greenleaf, CEO of MedImmune moderating a panel of five serial biotech entrepreneurs including: Mark Rampy, CEO of CohBar, Inc.; John Trizzino, CEO of ImmunoVaccine; Ken Carter, President & CEO of NexImmune, Inc.; Peter Kiener, President & CEO of Zyngenia; and Rahul Singhvi, Co-Founder of BioCycive.

# # #